Troponin I level in risk stratification of non-ST-elevation myocardial infarction in smokers
A prospective study was carried out to evaluate the role of troponin I in risk stratification of non-ST-elevation myocardial infarction in 40 smoker and 40 non-smoker patients. The troponin I was significantly higher (p<0.001) in smokers (35.5 ± 5.22 ng/mL) than non-smoker (0.27 ± 0.01 ng/mL). Th...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Bangladesh Pharmacological Society
2010-12-01
|
Series: | Bangladesh Journal of Pharmacology |
Subjects: | |
Online Access: | http://www.banglajol.info/index.php/BJP/article/view/6666/5242 |
Summary: | A prospective study was carried out to evaluate the role of troponin I in risk stratification of non-ST-elevation myocardial infarction in 40 smoker and 40 non-smoker patients. The troponin I was significantly higher (p<0.001) in smokers (35.5 ± 5.22 ng/mL) than non-smoker (0.27 ± 0.01 ng/mL). The duration of hospital stay was longer in Group I (106.6 ± 2.36 hour) than in Group II (49.20 ± 1.01 hour). The major adverse cardiac event was higher in smoker (71.79%) compared to non-smokers (10.8%). So, it may be concluded that higher value of troponin I with history of smoking in non-ST-elevation myocardial infarction may be considered as ‘high risk group’ patients. |
---|---|
ISSN: | 1991-007X 1991-0088 |